KA
CGEN icon

Klingman & Associates’s Compugen CGEN Stock Holding History

Klingman & Associates’s Portfolio CGEN Stock Details CGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-30,000
Closed -$363K – 174
2020
Q4 		$363K Hold
30,000
– – 0.04% 107
2020
Q3 		$488K Buy
+30,000
New +$492K 0.07% 83

Other funds holding CGEN

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Klingman & Associates's CGEN Position: Q1 2021 in Review

Klingman & Associates sold out of Compugen (CGEN) in Q1 2021, closing a stake of 30,000 shares — an estimated $363K sold.

Klingman & Associates first reported a position in CGEN in Q3 2020 and held it in 2 quarters. The position peaked at $488K in Q3 2020. 108 funds tracked by Wall St. Rank hold CGEN as of Q1 2021.

  • Klingman & Associates reported no remaining Compugen position as of Q1 2021 after selling out during the quarter.
  • Klingman & Associates sold 30,000 Compugen shares in Q1 2021, an estimated $363K.
  • Klingman & Associates first reported a position in Compugen in Q3 2020 and held it in 2 quarters.
  • Klingman & Associates's Compugen position peaked at $488K in Q3 2020.
  • 108 funds tracked by Wall St. Rank held Compugen as of Q1 2021.

Based on Klingman & Associates's 13F filing for Q1 2021, filed 29 Apr 2021.